Home » 論文ナビSCOPE » 機関×分野分析 » 【論文データ】順天堂大学の腫瘍学分野の研究動向まとめ 【論文データ】順天堂大学の腫瘍学分野の研究動向まとめ 論文ナビは研究者によって運営される論文解説プラットフォームです。このページでは、最近二年間(2016-2017)で発表された文献データを独自に収集・集計して分かりやすくまとめました。論文キーワードマップ、代表的な研究機関、頻出キーワード、分野のシェア、分野関連図、関連文献等により、今までない情報を提供します。 統計データ breast cancerlung cancernon-small-cell lung cancer (NSCLC)prognosissurgeryepidermal growth factor receptor (EGFR)methotrexatechemotherapylobectomyglioblastomametastasiscancerimmunotherapymelanomaPD 1macrophageesophageal squamous cell carcinomarheumatoid arthritisapoptosissurvivaldiagnosisS-1sepsismesotheliomapaclitaxelefficacyovarian cancerstereotactic radiotherapygastric cancerEpstein-Barr virusneoadjuvant chemotherapyrenal cell carcinoma (RCC)colorectal cancerbiomarkerlung adenocarcinomaimmune checkpoint inhibitorinvasionradiotherapycervical cancerprostate cancerIL-1 betaT790M mutationmalignant transformationbreast-conserving surgeryCD4 T-cellnext-generation sequencingoverall survivalTP53oral squamous cell carcinomaimmune responseadenocarcinomaproliferationcell cyclestagingoutcomedihydropyrimidine dehydrogenasethymidylate synthaseimmunohistochemistryDAMPsantimicrobial peptideneutrophil extracellular trapscathelicidincytokinemicroenvironmentphase I studyimmune checkpointclinical trialallergyageeribulinsafetytyrosine kinase inhibitormolecular targeted therapyPIK3CAadverse eventsgliomaRNA helicasestomach neoplasmtumor-infiltrating lymphocytecancer stem cellsenergy metabolismammoniamFOLFOX6preoperative chemotherapyrectal cancerHDRbrachytherapyprostatelung metastasispulmonary resectionrituximabsunitinibinterstitial lung diseaseNK celloncogeneserum biomarkerpancreatic cancermetabolismmantle-cell lymphomatreatmentinhibitorkinaseCRISPR/Cas9Hippo pathwayYAP1retrospective studybiliary tract cancerprognostic factormicrosatellite instabilityendocrine therapyhistone deacetylase inhibitordocetaxelprednisoloneprostatic neoplasmshypokalemiaabiraterone acetatedexamethasoneEpCAMepithelial-mesenchymal transitioncirculating tumor cellsALDH2CINVtumoradenosinecombination therapyhypercalcemiachronic lymphocytic leukemiaglucosaminenuclear factor (NF)-kappa Bsubstance Pgabapentinpregabalinp38 MAPKIL-6IL-8carboplatinperipheral neuropathytumor suppressorezrinpemetrexedmonoclonal antibodylymph node dissectioncomputed tomography (CT)nivolumabautoimmune diseasecluster analysisliver metastasisIgGmass spectrometryprostate-specific antigen (PSA)P-glycoproteinneutrophilIL-17gamma delta T cellCD30epidermal growth factor receptor mutationlymph node metastasisneuroendocrine tumorcolontumor microenvironmenthead and neck squamous cell carcinomaCTLA-4PET-CTmagnetic resonance imaging (MRI)migrationKRAS mutationcachexiaoncologylymphomaleukemiaradiationangiogenesislocal recurrenceintra-arterial chemotherapyDNA vaccinebevacizumabtreatment outcomeearly recurrencelate recurrencepercutaneous endoscopic gastrostomyCT angiographyacute myeloid leukemia (AML)RUNX1toxicityTGF-betaosteopontinIFN-gammainflammationIL-1 alphaanimal modeldrug developmentthymic carcinomaBRAFcerebral infarctionthrombosisbrain metastaseshepatic arterial infusion chemotherapynationwide surveyhepatocellular carcinoma (HCC)myeloproliferative neoplasmessential thrombocythemiapregnancyendometriumstem cellsmiscarriageepigeneticssenescenceprogression-free survivaladverse effecthysterectomyendometrial cancerSALL4Glypican-3bonediffuse large B-cell lymphomagenetic diagnosismetastatic breast cancerGNASgadoliniumcalcium phosphatenanoparticlesNY-ESO-1cancer immunotherapyquality-of-life (QOL)propensity scoresarcoma
